CY2281B1 - Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides - Google Patents

Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides

Info

Publication number
CY2281B1
CY2281B1 CY0200035A CY0200035A CY2281B1 CY 2281 B1 CY2281 B1 CY 2281B1 CY 0200035 A CY0200035 A CY 0200035A CY 0200035 A CY0200035 A CY 0200035A CY 2281 B1 CY2281 B1 CY 2281B1
Authority
CY
Cyprus
Prior art keywords
polysaccharides
pharmaceutical compositions
compositions containing
preparing same
synthetic
Prior art date
Application number
CY0200035A
Other languages
English (en)
Inventor
Philippe Duchaussoy
Jean-Marc Herbert
Guy Jaurand
Maurice Petitou
Van Constant Boeckel
Original Assignee
Sanofi Synthelabo
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo, Akzo Nobel Nv filed Critical Sanofi Synthelabo
Publication of CY2281B1 publication Critical patent/CY2281B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
CY0200035A 1996-06-14 2002-05-15 Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides CY2281B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9607457A FR2749849B1 (fr) 1996-06-14 1996-06-14 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
CY2281B1 true CY2281B1 (en) 2003-07-04

Family

ID=9493087

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200035A CY2281B1 (en) 1996-06-14 2002-05-15 Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides

Country Status (15)

Country Link
US (1) US7919614B2 (fr)
EP (1) EP0904299B1 (fr)
JP (1) JP3501813B2 (fr)
AT (1) ATE204883T1 (fr)
AU (1) AU3266797A (fr)
BR (1) BR9709722B1 (fr)
CA (1) CA2258146C (fr)
CY (1) CY2281B1 (fr)
DE (1) DE69706418T2 (fr)
DK (1) DK0904299T3 (fr)
ES (1) ES2163171T3 (fr)
FR (1) FR2749849B1 (fr)
NO (1) NO319037B1 (fr)
PT (1) PT904299E (fr)
WO (1) WO1997047659A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
EP1574516A1 (fr) * 2004-03-05 2005-09-14 Sanofi-Aventis Composés antithrombotiques
JP4796758B2 (ja) * 2004-08-24 2011-10-19 学校法人 京都産業大学 組成物及びそれを含有する抗腫瘍剤
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
WO2009155108A1 (fr) * 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Structures saccharides et procédés destinés à fabriquer et à utiliser de telles structures
FR2949114B1 (fr) * 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2970969B1 (fr) * 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
EP2578594A1 (fr) * 2011-10-04 2013-04-10 Sanofi Procédé pour la préparation de l'acide L-iduronique par une réaction decarboxylation/cyclisation intramoléculaire en tandem
WO2021211441A1 (fr) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Polymères du sucre modifiés à faible activité anticoagulante et activité thérapeutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382570A (en) * 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5529985A (en) * 1990-04-23 1996-06-25 Akzo Nobel Nv Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5668274A (en) * 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type

Also Published As

Publication number Publication date
ES2163171T3 (es) 2002-01-16
PT904299E (pt) 2002-02-28
EP0904299B1 (fr) 2001-08-29
FR2749849B1 (fr) 1998-09-04
JPH11513061A (ja) 1999-11-09
WO1997047659A1 (fr) 1997-12-18
NO985831L (no) 1999-02-11
US20040068108A1 (en) 2004-04-08
DE69706418D1 (de) 2001-10-04
DK0904299T3 (da) 2001-12-17
NO319037B1 (no) 2005-06-06
CA2258146C (fr) 2003-10-07
DE69706418T2 (de) 2002-05-29
FR2749849A1 (fr) 1997-12-19
JP3501813B2 (ja) 2004-03-02
NO985831D0 (no) 1998-12-11
BR9709722A (pt) 2000-01-25
ATE204883T1 (de) 2001-09-15
AU3266797A (en) 1998-01-07
CA2258146A1 (fr) 1997-12-18
BR9709722B1 (pt) 2010-12-14
US7919614B2 (en) 2011-04-05
EP0904299A1 (fr) 1999-03-31

Similar Documents

Publication Publication Date Title
NZ333721A (en) Pharmaceutically acceptable synthetic polysaccharides
CY2281B1 (en) Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides
FR2617848B1 (fr) Polysaccharides extraits, notamment, de vegetaux utiles comme medicaments et additifs alimentaires
PT94658A (pt) Processo para a preparacao de composicoes de base polimerica possuindo amido desestruturado e de produtos que as contem
DE3485588D1 (de) Chondroitin-sulfat/natriumhyaluronat-zusammensetzungen.
PT94657A (pt) Processo para a preparacao de uma composicao de mistura de base polimerica contendo amido desestruturado e de produtos que a contem
DE69116597D1 (de) Proteinase-resistente Cellulase, sie produzierender Mikroorganismus und Verfahren zu ihrer Herstellung
NL300231I2 (nl) Polyribosylribitolfosfaat omvattende entstofsamenstelling tegen haemophilus influenza type b en werkwijze voor de bereiding ervan.
TR26920A (tr) Kisa ya da uzun elyafa dönüstürülmek üzere amaclanmis cam hazirlama yöntemi.
EP0263703A3 (en) Lactone modified, esterified or aminated additives useful in oleaginous compositions
ES2059381T3 (es) Particulas polimeras producidas secuencialmente, dispersiones acuosas de particulas polimeras producidas secuencialmente, procedimientos para la preparacion de particulas polimeras producidas secuencialmente y usos de particulas polimeras producidas secuencialmente.
MX9705002A (es) Composicion de ensamblaje para hilos de vidrio, procedimiento que utiliza esta composicion y productos resultantes.
DE69805757D1 (de) Polysaccharid, mikroorganismus und verfahren zu dessen herstellung, dieses enthaltende zusammensetzung und verwendung
CA2019675A1 (fr) Polysaccharides cationiques et reactifs pour leur preparation
IE782127L (en) Microbial fractions.
ES8605041A1 (es) Procedimiento de preparacion de polisacaridos membranarios de origen bacteriano
PT1020474E (pt) Derivados de oligossacaridos e processo para a sua obtencao
CA2023058A1 (fr) Compose d'enduction a epaisseurs a base de polygalactomannans a groupes hydrophiles et hydrophobes
CA2079018A1 (fr) Un polysaccharide, ses applications, sa production par fermentation et la souche de pseudomonas qui le produit
ATE279445T1 (de) Regioselektiv substituierte ester von oligo- und polysacchariden und verfahren zu ihrer herstellung
BR8806293A (pt) Processo para a preparacao de diorganopolissiloxanos apresentando nas unidades terminais cada uma,um grupo hidroxila si-ligado
DE69218067D1 (de) Verfahren zur Herstellung von 3-deacylierten Derivaten eines 16-gliedrigen Macrolid-Antibiotikums, hierfür verwendeter Mikroorganismus, sowie neues Macrolid-Antibiotikum
ES8505383A1 (es) Procedimiento para la preparacion de sales de eritromicina, o sus esteres, con derivados acidos de la inosina
PL350611A1 (en) Substituted polysaccharide sulfates, method for producing them and their use as high-performance flow agents for cement mixtures
DE69111119D1 (de) Durch Fermentation hergestellte Polysaccharide.